v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
SCHEDULE OF REVENUE RECOGNITION UNDER GRANTS

The revenue recognized under the MPAR Grant and OUD Grant was as follows:

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
MPAR  $960,999   $1,319,772 
TAAP/OUD   -    - 
Total  $960,999   $1,319,772 
SCHEDULE OF UNBILLED RECEIVABLE

Unbilled receivable from the MPAR Grant consisted of the following:

 

   March 31, 2026   December 31, 2025 
Unbilled receivable - beginning  $420,345   $124,115 
Unbilled receivable - ending   -    420,345 
SCHEDULE OF WEIGHTED AVERAGE SHARES OF ANTI-DILUTIVE SECURITIES

The following weighted average shares have been excluded from the calculations of diluted weighted average common shares outstanding because they would have been anti-dilutive (the Company has utilized the principal balance outstanding and the end of period conversion price for the Convertible Notes for the purposes of the weighted average share calculation below):

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
Stock options   102,167    40,518 
Warrants   3,266,088    2,766,802 
Convertible Notes   2,265    2,265 
Consultant Shares   -    4,600 
Conversions from Preferred Shares   2,886,552    - 
Total   6,257,072    2,814,185